Eevia Health Plc Logo

Eevia Health Plc

Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.

EEVIA | SPGR

Overview

Corporate Details

ISIN(s):
FI4000496658
LEI:
743700NO7D0UA8J1MQ31
Country:
Finland
Address:
Koulukatu 14, FI-60100 SEINÄJOKI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eevia Health Plc is a life science company specializing in the development and manufacturing of scientifically validated, high-concentration bioactive plant extracts. The company processes wild-harvested and organically farmed Arctic raw materials, such as berries, into standardized polyphenol extracts for the dietary supplement and food industries. Its product lines include 'Condition-Specific Bioactives' targeting gut, kidney, and urinary microbiome health, with research extending to eye and cognitive function. Eevia Health operates with a focus on sustainability through its 'Nordic Green Chemistry' manufacturing process, emphasizing its commitment to potent, excipient-free ingredients under its 'Dose Matters™' philosophy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Eevia Health Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Eevia Health Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-12 Stein Ulve Other Other 2,726,717 54,534.34 EUR

Peer Companies

Company Country Ticker View
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan 4886
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan 4503

Talk to a Data Expert

Have a question? We'll get back to you promptly.